Sec. 20-618. (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.
60 words·~1 min read·
/ct/title-20/chapter-400j-pharmacy/20-618·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.